VKTX logo

Viking Therapeutics (VKTX) Cash from investing

annual CFI:

-$553.37M-$374.28M(-208.99%)
December 31, 2024

Summary

  • As of today (May 29, 2025), VKTX annual cash flow from investing activities is -$553.37 million, with the most recent change of -$374.28 million (-208.99%) on December 31, 2024.
  • During the last 3 years, VKTX annual CFI has fallen by -$591.33 million (-1557.76%).
  • VKTX annual CFI is now -1110.66% below its all-time high of $54.75 million, reached on December 31, 2022.

Performance

VKTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

quarterly CFI:

$63.24M+$56.66M(+860.59%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VKTX quarterly cash flow from investing activities is $63.24 million, with the most recent change of +$56.66 million (+860.59%) on March 31, 2025.
  • Over the past year, VKTX quarterly CFI has increased by +$523.04 million (+113.76%).
  • VKTX quarterly CFI is now at all-time high.

Performance

VKTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

TTM CFI:

-$30.33M+$523.04M(+94.52%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VKTX TTM cash flow from investing activities is -$30.33 million, with the most recent change of +$523.04 million (+94.52%) on March 31, 2025.
  • Over the past year, VKTX TTM CFI has increased by +$610.75 million (+95.27%).
  • VKTX TTM CFI is now -140.49% below its all-time high of $74.90 million, reached on September 30, 2022.

Performance

VKTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

VKTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-209.0%+113.8%+95.3%
3 y3 years-1557.8%+3806.4%-165.6%
5 y5 years-7514.8%+467.1%-215.7%

VKTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1110.7%at lowat high+113.8%-140.5%+95.3%
5 y5-year-1110.7%at lowat high+113.8%-140.5%+95.3%
alltimeall time-1110.7%at lowat high+113.8%-140.5%+95.3%

VKTX Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$63.24M(+860.6%)
-$30.33M(-94.5%)
Dec 2024
-$553.37M(+209.0%)
$6.58M(-74.6%)
-$553.37M(+5.6%)
Sep 2024
-
$25.90M(-120.5%)
-$524.22M(-6.8%)
Jun 2024
-
-$126.06M(-72.6%)
-$562.65M(-12.2%)
Mar 2024
-
-$459.79M(-1386.7%)
-$641.08M(+258.0%)
Dec 2023
-$179.09M(-427.1%)
$35.73M(-385.1%)
-$179.09M(-13.7%)
Sep 2023
-
-$12.53M(-93.9%)
-$207.56M(+23.5%)
Jun 2023
-
-$204.48M(-9403.1%)
-$168.13M(-403.9%)
Mar 2023
-
$2.20M(-69.7%)
$55.33M(+1.1%)
Dec 2022
$54.75M(+44.2%)
$7.26M(-73.0%)
$54.75M(-26.9%)
Sep 2022
-
$26.89M(+41.7%)
$74.90M(+21.5%)
Jun 2022
-
$18.98M(+1072.3%)
$61.63M(+33.4%)
Mar 2022
-
$1.62M(-94.1%)
$46.21M(+21.7%)
Dec 2021
$37.96M(-8.7%)
$27.41M(+101.3%)
$37.96M(-7.0%)
Sep 2021
-
$13.62M(+282.5%)
$40.82M(+132.3%)
Jun 2021
-
$3.56M(-153.7%)
$17.57M(-26.1%)
Mar 2021
-
-$6.63M(-121.9%)
$23.79M(-42.8%)
Dec 2020
$41.57M(+457.0%)
$30.27M(-414.2%)
$41.57M(>+9900.0%)
Sep 2020
-
-$9.63M(-198.5%)
$237.00K(-99.1%)
Jun 2020
-
$9.78M(-12.3%)
$25.02M(-4.6%)
Mar 2020
-
$11.15M(-200.8%)
$26.22M(+251.4%)
DateAnnualQuarterlyTTM
Dec 2019
$7.46M(-102.8%)
-$11.06M(-173.0%)
$7.46M(-106.0%)
Sep 2019
-
$15.15M(+38.0%)
-$123.87M(-25.4%)
Jun 2019
-
$10.98M(-244.3%)
-$166.11M(-31.8%)
Mar 2019
-
-$7.61M(-94.7%)
-$243.71M(-8.3%)
Dec 2018
-$265.73M(>+9900.0%)
-$142.39M(+425.7%)
-$265.73M(+108.0%)
Sep 2018
-
-$27.09M(-59.3%)
-$127.73M(+28.7%)
Jun 2018
-
-$66.63M(+124.9%)
-$99.26M(+197.2%)
Mar 2018
-
-$29.63M(+574.0%)
-$33.40M(+1830.4%)
Dec 2017
-$1.73M(-157.1%)
-$4.40M(-415.8%)
-$1.73M(-142.1%)
Sep 2017
-
$1.39M(-282.0%)
$4.11M(+30.1%)
Jun 2017
-
-$765.00K(-137.5%)
$3.16M(-449.8%)
Mar 2017
-
$2.04M(+40.9%)
-$903.90K(-129.8%)
Dec 2016
$3.03M(-122.5%)
$1.45M(+228.2%)
$3.03M(-14.4%)
Sep 2016
-
$441.00K(-109.1%)
$3.54M(-2390.3%)
Jun 2016
-
-$4.83M(-180.9%)
-$154.50K(-97.9%)
Mar 2016
-
$5.97M(+205.3%)
-$7.50M(-44.3%)
Dec 2015
-$13.47M
$1.96M(-160.1%)
-$13.47M(-12.7%)
Sep 2015
-
-$3.25M(-73.3%)
-$15.43M(+26.7%)
Jun 2015
-
-$12.17M(<-9900.0%)
-$12.17M(<-9900.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00
$0.00

FAQ

  • What is Viking Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Viking Therapeutics?
  • What is Viking Therapeutics annual CFI year-on-year change?
  • What is Viking Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Viking Therapeutics?
  • What is Viking Therapeutics quarterly CFI year-on-year change?
  • What is Viking Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Viking Therapeutics?
  • What is Viking Therapeutics TTM CFI year-on-year change?

What is Viking Therapeutics annual cash flow from investing activities?

The current annual CFI of VKTX is -$553.37M

What is the all time high annual CFI for Viking Therapeutics?

Viking Therapeutics all-time high annual cash flow from investing activities is $54.75M

What is Viking Therapeutics annual CFI year-on-year change?

Over the past year, VKTX annual cash flow from investing activities has changed by -$374.28M (-208.99%)

What is Viking Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of VKTX is $63.24M

What is the all time high quarterly CFI for Viking Therapeutics?

Viking Therapeutics all-time high quarterly cash flow from investing activities is $63.24M

What is Viking Therapeutics quarterly CFI year-on-year change?

Over the past year, VKTX quarterly cash flow from investing activities has changed by +$523.04M (+113.76%)

What is Viking Therapeutics TTM cash flow from investing activities?

The current TTM CFI of VKTX is -$30.33M

What is the all time high TTM CFI for Viking Therapeutics?

Viking Therapeutics all-time high TTM cash flow from investing activities is $74.90M

What is Viking Therapeutics TTM CFI year-on-year change?

Over the past year, VKTX TTM cash flow from investing activities has changed by +$610.75M (+95.27%)
On this page